Medical Health Cluster

Variantes Covid

OMS confirma 169 casos de nueva hepatitis aguda infantil en 11 países

Los casos de hepatitis aguda infantil de origen desconocido inicialmente reportados en Reino Unido siguen aumentando, y ya se han confirmado al menos 169 en 11 países, uno de ellos mortal, informó hoy la Organización Mundial de la Salud (OMS), que emitió recomendaciones para hacer frente a esta alerta sanitaria. La […]

Read More

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and ComorbiditiesThe I-TECH Randomized Clinical Trial

Key Points Question  Does adding ivermectin, an inexpensive and widely available antiparasitic drug, to the standard of care reduce the risk of severe disease in patients with COVID-19 and comorbidities? Findings  In this open-label randomized clinical trial of high-risk patients with COVID-19 in Malaysia, a 5-day course of oral ivermectin administered during […]

Read More

Expertos piden precaución; “pandemia aún no termina”

Luego de que el gobierno de Nuevo León anunció que a partir del próximo domingo será opcional el uso del cubreboca en lugares cerrados, especialistas alertan que la pandemia de Covid-19 no ha terminado, y no se justifica relajar las medidas preventivas como la de la mascarilla. Para el infectólogo […]

Read More

Un intervalo de tiempo mayor entre las vacunas Covid-19 genera hasta nueve veces más anticuerpos

Una nueva investigación, presentada en el Congreso Europeo de Microbiología Clínica y Enfermedades Infecciosas (ECCMID) de este año en Lisboa, ha demostrado que un intervalo más largo entre las dosis primarias de la vacuna COVID-19 puede aumentar la producción de anticuerpos hasta nueve veces. Comprender la respuesta inmunitaria a la vacunación contra la COVID-19 es fundamental para controlar […]

Read More

Receipt of COVID-19 Booster Dose Among Fully Vaccinated Pregnant Individuals Aged 18 to 49 Years by Key Demographics

Booster doses of COVID-19 vaccines were recommended for people aged 18 years or older in November 2021 following the recommendation of an additional primary dose of COVID-19 vaccine for select immunocompromised populations on August 13, 2021.1 As of February 26, 2022, more than 93 million booster doses of COVID-19 vaccines had […]

Read More

Patient Identified Who Battled COVID for 505 Days

Immunocompromised patients can harbour persistent SARS-CoV-2 infection for up to 505 days, show data from a patient who had the longest COVID-19 infection on record, according to a UK study looking at evolution of the virus. An immunocompromised patient who was initially infected with a pre-Alpha variant (most likely the […]

Read More

Malaria Diagnosis & Treatment in the United States

Healthcare providers should always obtain a travel history from febrile patients. Fever in a person who has recently traveled in a malaria-endemic area should always be immediately evaluated using the appropriate diagnostic tests for malaria. Diagnosis Rapid and accurate diagnosis of malaria is integral to the appropriate treatment of affected […]

Read More

Fractionating COVID-19 Vaccine Doses May Save Lives

Administering smaller doses of COVID-19 vaccines could be economically viable and could save more lives than either full-dose vaccination or no vaccination in low- and middle-income countries (LMICs)—even with the emergence of new, more highly transmissible variants, according to a cost-effectiveness modeling study. Assuming a vaccine supply shortage, the study estimated […]

Read More

WHO Urges Monitoring SARS-CoV-2 in Wildlife to Prevent Animal Reservoirs

Monitoring SARS-CoV-2 infections in animals is critical to prevent formation of animal reservoirs and to reduce risks of transmission to humans, according to a joint statement by the World Health Organization (WHO) and animal health partners. SARS-CoV-2 infection has been detected in wild, free-ranging, or captive animals including big cats, minks, ferrets, […]

Read More